The UK pharma company is teaming up with pioneer Craig Venter in a enormous project to discover new treatmentsAstraZeneca has teamed up with genome pioneer Craig Venter to launch a enormous gene hunt in the most comprehensive bet yet by a pharmaceutical firm on the potential of genetic variations to unlock routes to new medicines.
Related: Treatments for cancers and Alzheimer's on the verge of a breakthrough Continue reading...
Source: theguardian.com